Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands.
Annals of the rheumatic diseases（2023）
摘要
Based on these analyses, the 50% tapering approach saved the highest cost per QALY lost.
更多查看译文
关键词
Biological Therapy, Economics, Arthritis, Rheumatoid, Antirheumatic Agents
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要